Brevan Howard Capital Management LP Halozyme Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 20,996 shares of HALO stock, worth $1.37 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,996Holding current value
$1.37 Million% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding HALO
# of Institutions
550Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.15 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$865 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$468 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$272 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$225 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.08B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...